Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.
Mark C, Meshinchi S, Joyce B, Gibson B, Harrison C, Bergmann AK, Goemans BF, Pronk CJH, Lapillonne H, Leverger G, Antoniou E, Schneider M, Attarbaschi A, Dworzak M, Stary J, Tomizawa D, Ebert S, Lejman M, Kolb EA, Schmiegelow K, Hasle H, Abla O.
Mark C, et al.
Br J Haematol. 2024 Feb;204(2):576-584. doi: 10.1111/bjh.19067. Epub 2023 Sep 24.
Br J Haematol. 2024.
PMID: 37743097
The prognostic impact of PICALM::MLLT10 status in childhood leukaemia is not well described. ...Most patients received a chemotherapy regimen per their disease phenotype: 58% received an ALL regimen, 40% an AML regimen and 1% a hybrid regimen. Outcomes for children with …
The prognostic impact of PICALM::MLLT10 status in childhood leukaemia is not well described. ...Most patients received a chemotherapy …